Detalles de la búsqueda
1.
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 16(15): 1525-1536, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26429297
2.
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 59(6): 751-758, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402345
3.
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience.
Bone Marrow Transplant
; 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38773280
4.
Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study.
Leuk Res
; 142: 107529, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38820666
5.
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.
Bone Marrow Transplant
; 59(3): 380-386, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184740
6.
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemia.
Clin Case Rep
; 10(1): e05212, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35028141
7.
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series.
Bone Marrow Transplant
; 57(7): 1133-1141, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35513485
8.
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.
Immunobiology
; 225(6): 152001, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32943233
9.
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Lancet Haematol
; 7(1): e28-e39, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31606445
10.
Effectiveness of CAR-T treatment toward the potential risk of second malignancies.
Front Immunol
; 15: 1384002, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756776
Resultados
1 -
10
de 10
1
Próxima >
>>